CLASS II Drug recall · Reported 5 Aug 2020 · FDA Enforcement Report
Progesterone 150 mg Troche, 30 troches MasterPharm recalled
MasterPharm is recalling Progesterone 150 mg Troche, 30 troches MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY, distributed nationwide in the US. The recall was initiated on 2 Jul 2020 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1428-2020
- FDA event ID
- 85992
- Recalling firm
- MasterPharm, South Richmond Hill, NY
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 2 Jul 2020
- FDA classified
- 29 Jul 2020
- Reported
- 5 Aug 2020
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Hormones & Birth Control
Timeline
| 2 Jul 2020 | Recall initiated by company | |
| 29 Jul 2020 | Classified by FDA | +27 days |
| 5 Aug 2020 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of Processing Controls (lack of assurance of conformity to specifications).
Product as listed by the FDA
Progesterone 150 mg Troche, 30 troches MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419, (866) 630-5600
Where it was distributed
Nationwide in the U.S.
Questions about this recall
Why was it recalled?
Lack of Processing Controls (lack of assurance of conformity to specifications).
Which lots are affected?
02-06-2020:26@15, BUD 8/4/2020 02-07-2020:18@1, BUD 8/5/2020 02-12-2020:43@6, BUD 8/10/2020
Where was it sold?
Nationwide in the U.S.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
25 other products · FDA event 85992This product is part of a recall event; the main page for the event is Formula 82M (Minoxidil 5%/Tretinoin 0.01%/Fluocinolone recalled.
More recalls from MasterPharm
All 28| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estriol per, MasterPharm, 115-02 Liberty Ave, Richmond Hill recalled | MasterPharm | Other | Nationwide |
| Drug | CLASS II | Vardenafil 20 mg Troche, 30 troches per, MasterPharm recalled | MasterPharm | Other | Nationwide |
| Drug | CLASS II | Tadalafil per, MasterPharm, 115-02 Liberty Ave recalled | MasterPharm | Hidden Drug Ingredients | Nationwide |
| Drug | CLASS II | Minoxidil/Biotin/Spironolactone 1.25/5/25mg capsules recalled | MasterPharm | Other | Nationwide |
| Drug | CLASS II | Tadalafil per, MasterPharm, 115-02 Liberty Ave recalled | MasterPharm | Hidden Drug Ingredients | Nationwide |
Other Progesterone Troche recalls
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Progesterone 300 mg Troche, 30 troches per, MasterPharm recalled | MasterPharm | Other | Nationwide |
| Drug | CLASS II | Progesterone 200 mg Troche, 30 troches per, MasterPharm recalled | MasterPharm | Other | Nationwide |
| Drug | CLASS II | Progesterone 200 mg Troche recalled by MPRX | Mprx | Other | TX |